Literature DB >> 26458583

Effect of X-ray repair cross complementing group 1 polymorphisms on the efficacy of platinum-based chemotherapy in patients with nonsmall cell lung cancer.

Xiaohong Fan, Qingyu Xiu1.   

Abstract

AIMS: X-ray repair cross complementing group 1 (XRCC1) has been indicated to be correlated with the efficacy of platinum-based chemotherapy. But study results were still debatable. Thus, a meta-analysis was conducted.
MATERIALS AND METHODS: A literature search was performed using the PubMed, EMBASE, CNKI, with the databases being last accessed on November 24, 2014. Odds ratios with 95% confidence intervals were used to assess the strength of the association.
RESULTS: In this meta-analysis, we found that XRCC1 Arg194Trp polymorphism was significantly associated with the efficacy of platinum-based chemotherapy. However, XRCC1 Arg399Gln polymorphism showed no impact on the efficacy of platinum-based chemotherapy.
CONCLUSION: This meta-analysis suggested that the XRCC1 Arg194Trp polymorphism may be associated with efficacy of platinum-based chemotherapy. Further studies with a larger sample size are needed to further assess this result.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26458583     DOI: 10.4103/0973-1482.159085

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  2 in total

1.  Application of gene polymorphisms to predict the sensitivity of patients with locally advanced non-small cell lung cancer undergoing chemoradiotherapy.

Authors:  Yue Zhao; Yun Xie; Dianjun Jia; Chiluan Ma; Dongdong Wei; Xiaoyu Zhang
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

2.  Meta-analysis of XRCC1 polymorphism and risk of female reproductive system cancer.

Authors:  Na-Na Yang; Ying-Fan Huang; Jian Sun; Ying Chen; Zhong-Min Tang; Jin-Fang Jiang
Journal:  Oncotarget       Date:  2017-04-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.